Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02280733 · ClinicalTrials.gov registry record
A Real-World Registry of Chronic Wounds and Ulcers
A clinical trial of Peripheral Arterial Disease and Lymphedema, sponsored by U.S. Wound Registry.
- Recruiting
- Registry status
- 300,000
- Enrollment target
- 1
- Study location
NCT02280733: Recruiting study of Peripheral Arterial Disease and Lymphedema, sponsored by U.S. Wound Registry.
NCT02280733 is a study of Peripheral Arterial Disease and Lymphedema that is actively recruiting participants, run by U.S. Wound Registry. The registered enrollment target is 300,000 participants, above the 409-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (73250% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02280733, a study of Peripheral Arterial Disease and Lymphedema, is actively recruiting participants, sponsored by U.S. Wound Registry.
- RECRUITING
- Registry status
- 300,000 participants
- Enrollment target
- 1
- Study location
Study Summary
WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data are collected during routine care from over 1,400 clinicians across the USA and Puerto Rico using a highly structured certified electronic health record (EHR) or electronic data capture (EDC) system. Data are transmitted daily to the U.S. Wound Registry (USWR), a CMS-recognized Qualified Clinical Data Registry (QCDR). The registry captures real-time, research-ready data on patient demographics, comorbidities, wound characteristics, standard-of-care treatments, complications, and advanced therapeutics. It supports robust, fit-for-purpose real-world evidence generation by enabling risk-adjusted outcome analysis, comparative effectiveness research, and quality improvement across diverse sites of care.
Primary Outcome
Wound closure by secondary intention
Conditions Studied
Interventions
- OTHER Usual care
Study Locations (1)
Texas
- US Wound Registry - The Woodlands
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300,000 participants |
| Start Date | 2005-01-01 |
| Est. Completion | 2030-01 |
What NCT02280733 shows while recruiting
NCT02280733 is an observational study that tracks outcomes without assigning an intervention. Its 300,000 participants enrollment target places it among the larger protocols in the corpus, above the 409-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (73250% higher).
The record links to 10 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Usual care is the first listed.
NCT02280733 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02280733 about?
NCT02280733 is a clinical study titled "A Real-World Registry of Chronic Wounds and Ulcers". WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data are collected during routine care from over 1,400 clinicians across the USA and Puerto Rico using a highly structured ce...
What is the current status of trial NCT02280733?
This trial is currently recruiting. The enrollment target is 300,000 participants. The study started on 2005-01-01. Estimated completion is 2030-01.
What conditions does trial NCT02280733 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Lymphedema, Diabetic Foot, Vasculitis, Pressure Ulcer.
What interventions are being tested in trial NCT02280733?
The interventions under investigation include: Usual care (OTHER).
Who is sponsoring clinical trial NCT02280733?
This trial is sponsored by U.S. Wound Registry, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02280733 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02280733's enrollment target sits among peer trials
300,000 1st of 79 higher than 79 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06694181 · 300,000 participants
Safe and Explainable AI
- NCT07314697 · 300,000 participants · NA
Arrival Time Implementation
- NCT05365048 · 301,201 participants · NA
Provider Recommendation and HPV Vaccination
- NCT05668637 · 318,542 participants
Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI